Ribbon Secures $100M Equity Line and $1M Convertible Note from Meteora Ahead of DRC Medicine Merger
RIBB is trading near its 52-week low of $9.95 (9.0% above the low) on elevated volume (18× avg).
Summary
Ribbon Acquisition Corp. entered into a $100M standby equity purchase agreement and a $1M convertible note with Meteora, providing critical capital ahead of its DRC Medicine merger but with highly dilutive terms.
Key Events · Financing and Capital Events · RIBB
-
$100M Standby Equity Purchase Agreement
Ribbon entered into a SEPA with Meteora Select Trading Opportunities Master, LP allowing the company to sell up to $100 million of common shares over 36 months at 97% of market price, with a 1.75% commitment fee ($1.75M).
-
$1M Convertible Note with 17.5% OID
Ribbon issued a $1,212,121 convertible promissory note to Meteora for $1,000,000 in net proceeds (17.5% original issue discount), maturing 12 months after the business combination closes, with a 7% payment premium and 18% default interest.
-
Variable-Rate Conversion Feature
The Note converts at the lower of a fixed price or 95% of the lowest daily VWAP over the preceding 5 trading days, subject to a floor price, creating significant potential dilution.
-
9.9% Share Escrow as Collateral
Upon closing, certain PubCo shareholders will deposit 9.9% of outstanding shares into escrow; title transfers to Meteora upon any event of default under the Note.
Analysis · RIBB · Real Estate & Construction
Ribbon Acquisition Corp. has entered into a complex, multi-agreement financing package with Meteora Select Trading Opportunities Master, LP that provides up to $100 million in standby equity capital plus a $1 million convertible note. The terms are highly dilutive and include a variable-rate conversion feature, a 17.5% original issue discount, a 7% payment premium, and a 9.9% escrow of post-merger shares as collateral. This financing is critical because Ribbon's trust account has been depleted to $38.4 million after massive redemptions, and the company has a going concern warning and a $1.8 million working capital deficit. The deal is structured to close concurrently with the pending business combination with DRC Medicine Ltd., which has been extended multiple times and is now scheduled for a shareholder vote. The financing provides essential runway but at a steep cost to existing shareholders.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.7% of the 583 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RIBB was trading at $10.85 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $68M. The 52-week trading range was $9.95 to $10.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.